Biogen Inc. (BIIB) Q4 Earnings and Revenues Surpass Estimates
Portfolio Pulse from
Biogen Inc. (BIIB) reported Q4 earnings of $3.44 per share, surpassing the Zacks Consensus Estimate of $3.42 and improving from $2.95 a year ago.
February 12, 2025 | 2:30 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Biogen Inc. reported Q4 earnings of $3.44 per share, exceeding expectations and showing growth from the previous year.
Biogen's earnings per share exceeded analyst expectations and showed year-over-year growth, which is likely to positively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100